Action Organon - OGN

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

15,35

Prix Achat

Prix Vente

Volume échangé

4 425 609

15,25 Fourchette du Jour 16,50

13,87 Plage de 52 semaines 23,10

Cap du marché

3,953B

Clôture Veille

16,32

Ouverture

16,14

Dernière Transaction

15.37

Dernière heure de transaction

Volume financier

US$ 69 441 678

VWAP

15,6909

Volume moyen (3 m)

3 417 617

Actions en circulation

257 538 875

Rendement du Dividende

7.30%

Ratio Cours sur Bénéfices

3,84

Bénéfice par action (BPA)

3,97

Chiffre d'affairess

6,26B

Bénéfice net

1,02B

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada. Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.organon.com

Siège social

Wilmington, Delaware, USA

Fondé

Organon and Co est coté dans le secteur Pharmaceutical Preparations de la New York Stock Exchange avec le ticker OGN. Le dernier cours de clôture d'Organon était de US$16,32. Au cours de la dernière année, les actions de Organon ont été négociées dans une fourchette de prix de US$ 13,87 à US$ 23,10.

Organon compte actuellement 257 538 875 actions en circulation. La capitalisation boursière d'Organon est de US$4,20 milliard. Organon a un ratio cours/bénéfice (ratio PE) de 3.84.

Flux global

Haussier

Prime nette

603k

Calls / Puts

100,00%

Ach. / Vent.

200,00%

OTM / ITM

100,00%

Sweeps Ratio

0,00%

Form 8-K - Current report

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024

Full year 2024 revenue of $6.4 billion, up 2% as-reported and 3% at constant currency Full year 2024 diluted earnings per share of $3.33 and...

Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025

Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its fourth quarter and full year 2024 financial...

Form 8-K - Current report

Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to...

FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

EFFICACY: In the pivotal studies, ADORING 1 and ADORING 2, up to 46% of patients on VTAMA cream achieved vIGA-AD™ treatment success at Week 8...

Form 8-K - Current report

Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced that the...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.45	3.02013422819	14.9	17.23	14.53	3793828	15.45424678	CS
4	-0.74	-4.59912989434	16.09	17.23	14.53	2760590	15.54136005	CS
12	0.41	2.74431057564	14.94	17.23	13.87	3417617	15.25126507	CS
26	-5.03	-24.6810598626	20.38	23.1	13.87	2736168	16.62708129	CS
52	-0.93	-5.71253071253	16.28	23.1	13.87	2376060	17.78200857	CS
156	-19.35	-55.7636887608	34.7	39.475	10.835	2476432	21.03241907	CS
260	-18.85	-55.1169590643	34.2	39.475	10.835	2521454	23.26052543	CS

OGN - Frequently Asked Questions (FAQ)

What is the current Organon share price?

The current share price of Organon is US$ 15,35

How many Organon shares are in issue?

Organon has 257 538 875 shares in issue

What is the market cap of Organon?

The market capitalisation of Organon is USD 4,2B

What is the 1 year trading range for Organon share price?

Organon has traded in the range of US$ 13,87 to US$ 23,10 during the past year

What is the PE ratio of Organon?

The price to earnings ratio of Organon is 3,84

What is the cash to sales ratio of Organon?

The cash to sales ratio of Organon is 0,63

What is the reporting currency for Organon?

Organon reports financial results in USD

What is the latest annual turnover for Organon?

The latest annual turnover of Organon is USD 6,26B

What is the latest annual profit for Organon?

The latest annual profit of Organon is USD 1,02B

What is the registered address of Organon?

The registered address for Organon is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Organon website address?

The website address for Organon is www.organon.com

Which industry sector does Organon operate in?

Organon operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
NUSNu Skin Enterprises Inc	US$ 7,55 (17,60%)	3,59M
PCORProcore Technologies Inc	US$ 87,50 (16,51%)	4,58M
LANVLanvin Group Holdings Limited	US$ 1,85 (16,35%)	64,01k
ZHZhihu Inc	US$ 5,31 (15,43%)	4,06M
CAECae Inc	US$ 26,8085 (14,03%)	1,85M
GWHESS Tech Inc	US$ 4,01 (-26,96%)	330,85k
INFAInformatica Inc	US$ 19,75 (-21,53%)	27,95M
SASeabridge Gold Inc	US$ 11,28 (-15,38%)	3,54M
TWLOTwilio Inc	US$ 125,17 (-15,01%)	15,5M
HLHecla Mining Company	US$ 5,42 (-14,91%)	33,12M
BBAIBigBear ai Holdings Inc	US$ 9,015 (-7,82%)	84,26M
NIONIO Inc	US$ 4,43 (3,99%)	54,3M
FFord Motor Company	US$ 9,4701 (1,28%)	53,78M
BABAAlibaba Group Holding Limited	US$ 124,73 (4,34%)	52,74M
QBTSD Wave Quantum Inc	US$ 6,37 (-2,00%)	52,14M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Organon and Co (OGN) Cours

Organon and Co (OGN)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Organon and Co

Flux d'options Organon (OGN)

Flux global

Haussier

Prime nette

603k

Calls / Puts

100,00%

Ach. / Vent.

200,00%

OTM / ITM

100,00%

Sweeps Ratio

0,00%

OGN Dernières nouvelles

Form 8-K - Current report

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024

Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025

Form 8-K - Current report

Form 8-K - Current report

Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference

FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

Form 8-K - Current report

Form 8-K - Current report

Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

Form 8-K - Current report

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024

Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025

Form 8-K - Current report

Form 8-K - Current report

Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference

FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

Form 8-K - Current report

Form 8-K - Current report

Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

米国FDAが、PROLIA/XGEVA（デノスマブ）のバイオシミラー候補HLX14の生物学的製剤承認申請（BLA）を受理

OGN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités